MGB-BP-3

N/A

Report date: 2025/04/20 20:00:03
NMEQIDP

Base Information

Drug NameMGB-BP-3
Drug Alias NameMGB-BP-3MGB-BP03
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionGenetic transcription inhibitors
TargetsNot applicable
Therapy Area/IndicationsClostridium Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMgb Biopharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMgb Biopharma Ltd
Active IndicationsN/A
Inactive IndicationsClostridium Infections

Other Information

ATC CodeN/A
Related LinksN/A